Benzinga  Oct 14  Comment 
In a report published Tuesday, Morgan Stanley analyst Joseph Moore reiterated an Equal-Weight rating on Intermolecular (NASDAQ: IMI). In the report, Morgan Stanley noted, “This appears to be an orderly transition from the Founder, who built...
SeekingAlpha  Aug 1  Comment 
Intermolecular, Inc. (NASDAQ:IMI) Q2 2014 Results Earnings Conference Call August 1, 2014 8:30 AM ET Executives Rick Neely - Senior Vice President and CFO Dave Lazovsky - President and CEO Analysts Harlan Sur - JPMorgan ...
Benzinga  May 20  Comment 
Dick's Sporting Goods (NYSE: DKS) shares tumbled 15.59% to $44.87 after the company reported quarterly results and cut its FY14 earnings forecast. Intermolecular (NASDAQ: IMI) shares slipped 11.87% to $2.79 after jumping around 39% on...
Benzinga  May 20  Comment 
In a report published Tuesday, Morgan Stanley analyst Joseph Moore reiterated an Equal-Weight rating on Intermolecular (NASDAQ: IMI). In the report, Morgan Stanley noted, “We believe the lost SNDK/Toshiba development revenues were about $7 mm...
Benzinga  May 19  Comment 
Gainers Intermolecular (NASDAQ: IMI) -35.24 percent - SanDisk and Toshiba license Intermolecular IP. InterMune (NASDAQ: ITMN) -12.62 percent - Upgrade from Leerink and good lung drug data. Senomyx (NASDAQ: SNMX) -10.46 percent -...
Benzinga  May 19  Comment 
TheStreet.com  May 19  Comment 
NEW YORK (TheStreet) -- Shares of Intermolecular Inc. are skyrocketing 43.17% to $3.25 on Monday following the company's announcement that SanDisk Corp. and Toshiba have jointly elected to take an exclusive license, in a limited field, to...


Intermolecular (NASDAQ:IMI) is a research and development firms which partners with semiconductor and clean energy firms to improve their innovative abilities and time to market constraints. IMI creates interdisciplinary teams which works with clients to help them develop proprietary technologies faster than they would with traditional research and development. The company is focused mostly on high-volume semiconductor businesses. Intermolecular makes money by charging its clients service fees during their collaboration and royalty fees once the client begins to commercialize the product.[1]

Business Overview

For the full year 2010, Intermolecular's total revenue was $42.7M. This corresponds to a 57% increase over the $26.9M of total revenue reported for the full year 2009. However, the company reported a net loss of $1.8M for 2010. During the first 9 months of 2011, Intermolecular reported a net loss of $4.5M.[2]

New Updates

The company's initial public offering of stock on the NASDAQ occurred on November 17, 2011. The company offered 9.65M shares each for $10. This was at the bottom of the $12-$14 price range. The company had originally announced that it would sell 10M shares. The deal raised a total of $9.65M. The lead mangers of the deal were Morgan Stanley, JP Morgan, and Barclays.

Trends & Forces

Focus on semiconductors

Intermolecular has focused historically on semiconductor companies, but the company hopes to enter into clean tech, LEDs, and photovoltaics. The company hopes that this will help to diversify as well as expand the business substantially. However, the differences in processes and technologies involved in these industries may vary greatly. As a result, Intermolecular may not maintain significant advantages in experience. Furthermore, the company's unique model for improving research and development may not directly carry over. [3]

  1. IMI S-1/A 2011 PROSPECTUS SUMMARY "Our Company" p. 1-2
  2. IMI S-1/A 2011 PROSPECTUS SUMMARY "Summary Consolidated Financial Data" p. 9
  3. Seeking Alpha "Intermolecular Prices Friday's IPO at $13" 16 Nov 2011
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki